Tangshan Sanyou Chemical Industries Co.,Ltd

SSE:600409.SS

5.09 (CNY) • At close April 29, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 21,361.18621,920.09223,679.82123,182.24917,780.27720,515.13520,173.73720,195.73115,756.79913,693.85312,695.35111,786.86210,484.0910,240.1595,304.9163,587.5745,084.1733,874.3182,578.7592,143.8921,496.583995.846944.375878.027811.327
Cost of Revenue 17,942.06917,506.83519,106.43918,054.12614,528.99116,395.43514,789.51714,674.81211,835.22510,720.71510,138.3729,662.2688,972.9818,272.5484,331.7493,059.7974,214.9312,915.1031,930.5631,667.7581,090.208746.099666.146654.822566.538
Gross Profit 3,419.1184,413.2584,573.3825,128.1233,251.2854,119.75,384.225,520.9193,921.5742,973.1382,556.9792,124.5951,511.1091,967.611973.168527.777869.242959.215648.196476.134406.375249.746278.23223.205244.789
Gross Profit Ratio 0.160.2010.1930.2210.1830.2010.2670.2730.2490.2170.2010.180.1440.1920.1830.1470.1710.2480.2510.2220.2720.2510.2950.2540.302
Reseach & Development Expenses 607.492595.513330.222221.356192.85254.46948.14869.46393.19110.65959.20149.62621.51318.28414.6570000000000
General & Administrative Expenses 1,244.7661,500.676326.05320.125325.964347.827270.492314.147272.936228.308217.473208.223205.132151.14179.693216.487271.711222.423194.101115.37599.29379.81873.651.29761.178
Selling & Marketing Expenses 51.87373.869210.822205.658180.069918.008834.447842.588778.157656.599460.535383.699331.738327.988185.398162.209224.584194.552157.191131.108101.58869.01849.54736.38137.193
SG&A 1,296.6391,546.732536.872525.783506.0331,265.8341,104.9391,156.7351,051.094884.908678.007591.922536.87479.129265.091378.696496.295416.975351.292246.483200.881148.835123.14787.67898.371
Other Expenses 755.033838.7561,534.8551,657.5261,249.8391,261.716-124.676-62.54440.51571.94726.3137.97929.63313.5166.4113.03118.1242.501-28.083-6.358-5.5062.033-4.8082.419-3.125
Operating Expenses 2,659.1642,981.0022,401.9492,404.6651,948.7252,582.0192,617.4032,517.8352,166.4071,790.0031,361.4911,181.6121,019.134905.698488.681394.128529.856447.286370.377260.511208.688155.333130.34493.625102.959
Operating Income 759.9541,432.2561,710.2292,316.2781,412.3611,540.8112,234.0392,606.3341,105.047531.84631.998500.695139.06771.583372.4177.824285.51467.567241.357194.223179.70782.035127.191111.288120.944
Operating Income Ratio 0.0360.0650.0720.10.0790.0750.1110.1290.070.0390.050.0420.0130.0750.070.0220.0560.1210.0940.0910.120.0820.1350.1270.149
Total Other Income Expenses Net 70.724-17.61-21.037-10.359-526.865-604.446-124.676-62.544-574.265-3.75110.42729.813-295.994-214.808-10.103-54.137.277-6.996-29.015-23.667-30.758-1.863-6.405-3.487-4.233
Income Before Tax 830.6781,414.6461,689.1922,305.92885.496936.3652,109.3622,543.7891,077.862528.089642.425530.519159.514781.493362.4479.52302.578460.571214.281189.911170.56480.172120.786107.801116.711
Income Before Tax Ratio 0.0390.0650.0710.0990.050.0460.1050.1260.0680.0390.0510.0450.0150.0760.0680.0220.060.1190.0830.0890.1140.0810.1280.1230.144
Income Tax Expense 176.795482.444364.934456.501132.593196.369407.841529.785276.993143.972157.37681.61250.205191.06367.83228.52770.38190.60659.02562.20158.55531.53745.28536.03940.735
Net Income 499.025565.6721,324.2581,671.007717.058682.9161,586.0791,889.077762.86412.607477.151445.17113.615586.665288.76738.466206.046323.554139.327126.649111.96948.90975.18972.14877.593
Net Income Ratio 0.0230.0260.0560.0720.040.0330.0790.0940.0480.030.0380.0380.0110.0570.0540.0110.0410.0840.0540.0590.0750.0490.080.0820.096
EPS 0.240.270.640.810.350.330.770.970.410.220.260.240.0620.370.250.0270.140.370.120.0970.0640.0280.060.0550.059
EPS Diluted 0.240.270.640.810.350.330.770.970.410.220.260.240.0620.370.250.0270.140.370.120.0970.0640.0280.060.0550.059
EBITDA 2,212.7942,881.2013,164.9243,817.8552,369.2652,437.543,479.43,915.5392,487.1751,909.3661,857.8291,566.0051,009.3161,433.639770.577319.983559.26660.649350.824297.611251.972151.097173.697157.172141.365
EBITDA Ratio 0.1040.1310.1340.1650.1330.1190.1720.1940.1580.1390.1460.1330.0960.140.1450.0890.110.1710.1360.1390.1680.1520.1840.1790.174